Identification of Substituted Pyrimido[5,4-b]indoles as Selective Toll-Like Receptor 4 Ligands
Open Access
- 24 May 2013
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 56 (11) , 4206-4223
Abstract
A cell-based high-throughput screen to identify small molecular weight stimulators of the innate immune system revealed substituted pyrimido[5,4-b]indoles as potent NFκB activators. The most potent hit compound selectively stimulated Toll-like receptor 4 (TLR4) in human and mouse cells. Synthetic modifications of the pyrimido[5,4-b]indole scaffold at the carboxamide, N-3, and N-5 positions revealed differential TLR4 dependent production of NFκB and type I interferon associated cytokines, IL-6 and interferon γ-induced protein 10 (IP-10) respectively. Specifically, a subset of compounds bearing phenyl and substituted phenyl carboxamides induced lower IL-6 release while maintaining higher IP-10 production, skewing toward the type I interferon pathway. Substitution at N-5 with short alkyl substituents reduced the cytotoxicity of the leading hit compound. Computational studies supported that active compounds appeared to bind primarily to MD-2 in the TLR4/MD-2 complex. These small molecules, which stimulate innate immune cells with minimal toxicity, could potentially be used as adjuvants or immune modulators.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases
This publication has 36 references indexed in Scilit:
- Analysis of high‐throughput screening assays using cluster enrichmentStatistics in Medicine, 2012
- Lipid A antagonist, lipid IVa, is distinct from lipid A in interaction with Toll-like receptor 4 (TLR4)-MD-2 and ligand-induced TLR4 oligomerizationInternational Immunology, 2004
- Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: Activation of Toll-like receptor 7Proceedings of the National Academy of Sciences, 2003
- Cutting Edge: A Novel Toll/IL-1 Receptor Domain-Containing Adapter That Preferentially Activates the IFN-β Promoter in the Toll-Like Receptor SignalingThe Journal of Immunology, 2002
- NF-κB regulation in the immune systemNature Reviews Immunology, 2002
- Essential role of MD-2 in LPS responsiveness and TLR4 distributionNature Immunology, 2002
- Enhancement of Innate Immunity againstMycobacterium aviumInfection by Immunostimulatory DNA Is Mediated by Indoleamine 2,3-DioxygenaseInfection and Immunity, 2001
- A human homologue of the Drosophila Toll protein signals activation of adaptive immunityNature, 1997
- CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding ProteinScience, 1990
- Synthesis of 3‐substituted thieno[2,3‐d]pyrimidin‐4 (3H)‐one‐2‐mercaptoacetic acids and their ethyl esters for pharmacological screeningJournal of Pharmaceutical Sciences, 1976